Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

´ëÀå¾Ï¿¡¼­ Æó»öÀÌ ¿¹ÈÄ¿¡ ¹ÌÄ¡´Â ¿µÇâ The Prognostic Impact of Obstructed Colorectal Cancer

´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö 2008³â 24±Ç 6È£ p.479 ~ 486
Á¤È­°æ, Á¤»óÈÆ, ±èÀçȲ, ½É¹Îö,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤È­°æ ( Jung Hwa-Kyung ) 
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Á¤»óÈÆ ( Jung Sang-Hun ) 
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±èÀçȲ ( Kim Jae-Hwang ) 
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
½É¹Îö ( Shim Min-Chul ) 
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract


Purpose: An obstructed colorectal cancer (OB) has a poorer survival than a non-obstructed cancer (NOB). This study examined the prognostic impact of bowel obstruction on colorectal cancer.

Methods: From December 1999 to December 2005, patients undergoing single stage operation for OB were examined prospectively. OB (n=193) was compared with a NOB (n=444) used in a primary tumor resection during the same period. 637 colorectal cancers were examined in this study.

Results: The overall operative mortality was 21 (3.3%) and the postoperative mortality was significantly higher in the OB (OB: 16, 8.3%) group than in the NOB (NOB: 5, 1.1%) group. The proportion of OB was higher in the left-colon (52.8%) than in the right colon (16.0%) and rectum (31.1%, P£¼0.001). However, OB was associated with an older age (P=0.013). The proportion of advanced tumor stage was higher in OB (II: 35.8%, III: 39.5%, IV: 24.7%) than in NOB (II: 53.2%, III: 35.8%, IV: 11.0%, P£¼0.001). The 5-year cancer-related survival for OB was worse than NOB (OB: 77.3%, NOB: 57.8%, P£¼0.05). However, in the cases of a colorectal cancer performed curative resection (stage II and III), the survival for OB was not worse than NOB: stage II (OB: 82.8%, NOB: 92.2%, P=0.24), stage III (OB: 65.2%, NOB: 56.9%, P=0.43).
Conclusions: OB has older and more advanced disease characteristics. However, if an oncologically curative resection is performed, the survival for OB is similar to that of a NOB.

Å°¿öµå

Æó»ö¼º ´ëÀå¾Ï;Á¾¾ç°ü·Ã »ýÁ¸À²
Obstructed colorectal cancer;Cancer related survival rate

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS